Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.

NCT04552600 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Nuvastatic
OTHER: Placebo

Sponsor

Natureceuticals Sdn Bhd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]